A detailed history of Callan Family Office, LLC transactions in Amgen Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 2,144 shares of AMGN stock, worth $567,066. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,144
Previous 1,994 7.52%
Holding current value
$567,066
Previous $623 Million 10.88%
% of portfolio
0.12%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$309.38 - $337.38 $46,407 - $50,607
150 Added 7.52%
2,144 $691 Million
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $216,768 - $263,430
825 Added 70.57%
1,994 $623 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $314,309 - $379,410
1,169 New
1,169 $332 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.